Loading...
Loading...
Jim Cramer said on
CNBC's Mad Money that his charitable trust fund had to decrease its position in
Lockheed Martin CorporationLMT because the stock moved higher and it became a too big part of the portfolio. He added that the stock is in a really good shape for the future.
Cramer would not be a seller of
Celgene CorporationCELG and
Regeneron Pharmaceuticals IncREGN. He is more inclined to be a buyer.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in